Pneumococcal components induce regulatory T cells that attenuate the development of allergic airways disease by deviating and suppressing the immune response to allergen

Journal of Immunology

Volumn 191, Issue 8, 2013, Pages 4112-4120

  Thorburn, Alison N ^a,b,c   Brown, Alexandra C ^a,b   Nair, Prema M ^a,b   Chevalier, Nina ^c,d   Foster, Paul S ^a,b   Gibson, Peter G ^a,b   Hansbro, Philip M ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR7; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOLYSOID; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ALLERGIC AIRWAY INFLAMMATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL EXPANSION; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG MECHANISM; EX VIVO STUDY; FEMALE; FUNCTIONAL STATUS; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; MYELOID DENDRITIC CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; STREPTOCOCCUS PNEUMONIAE; TH17 CELL; TH2 CELL;

ANIMALS; ANTIGENS, CD86; ASTHMA; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; INFLAMMATION; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-6; LUNG; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; OVALBUMIN; POLYSACCHARIDES, BACTERIAL; RECEPTORS, CCR7; STREPTOCOCCUS PNEUMONIAE; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84885437985     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201232     Document Type: Article

References (43)

1. Hansbro, P. M., G. E. Kaiko, and P. S. Foster. 2011. Cytokine/anti- cytokine therapy-novel treatments for asthma? Br. J. Pharmacol. 163: 81-95.
2. Thorburn, A. N., and P. M. Hansbro. 2010. Harnessing regulatory T cells to suppress asthma: from potential to therapy. Am. J. Respir. Cell Mol. Biol. 43: 511-519.
3. Afshar, R., B. D. Medoff, and A. D. Luster. 2008. Allergic asthma: a tale of many T cells. Clin. Exp. Allergy 38: 1847-1857.
4. Gavin, M. A., J. P. Rasmussen, J. D. Fontenot, V. Vasta, V. C. Manganiello, J. A. Beavo, and A. Y. Rudensky. 2007. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445: 771-775.
5. Kim, B.-S., I.-K. Kim, Y.-J. Park, Y.-S. Kim, Y.-J. Kim, W.-S. Chang, Y.-S. Lee, M.-N. Kweon, Y. Chung, and C.-Y. Kang. 2010. Conversion of Th2 memory cells into Foxp3+ regulatory T cells suppressing Th2-mediated allergic asthma. Proc. Natl. Acad. Sci. USA 107: 8742-8747.
6. Lee, J. H., H. H. Yu, L. C. Wang, Y. H. Yang, Y. T. Lin, and B. L. Chiang. 2007. The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma. Clin. Exp. Immunol. 148: 53-63.
7. Grindebacke, H., K. Wing, A. C. Andersson, E. Suri-Payer, S. Rak, and A. Rudin. 2004. Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season. Clin. Exp. Allergy 34: 1364-1372.
8. Preston, J. A., A. N. Thorburn, M. R. Starkey, E. L. Beckett, J. C. Horvat, M. A. Wade, B. J. O'Sullivan, R. Thomas, K. W. Beagley, P. G. Gibson, et al. 2011. Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells. Eur. Respir. J. 37: 53-64.
9. Preston, J. A., A.-T. Essilfie, J. C. Horvat, M. A. Wade, K. W. Beagley, P. G. Gibson, P. S. Foster, and P. M. Hansbro. 2007. Inhibition of allergic airways disease by immunomodulatory therapy with whole killed Streptococcus pneumoniae. Vaccine 25: 8154-8162.
10. Thorburn, A. N., B. J. O'Sullivan, R. Thomas, R. K. Kumar, P. S. Foster, P. G. Gibson, and P. M. Hansbro. 2010. Pneumococcal conjugate vaccineinduced regulatory T cells suppress the development of allergic airways disease. Thorax 65: 1053-1060.
11. Thorburn, A. N., P. S. Foster, P. G. Gibson, and P. M. Hansbro. 2012. Components of Streptococcus pneumoniae suppress allergic airways disease and natural killer T cells by inducing regulatory T cells. J. Immunol. 188: 4611-4620.
12. Horvat, J. C., M. R. Starkey, R. Y. Kim, S. Phipps, P. G. Gibson, K. W. Beagley, P. S. Foster, and P. M. Hansbro. 2010. Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology. J. Allergy Clin. Immunol. 125: 617-625.e616.
13. Essilfie, A.-T., J. L. Simpson, J. C. Horvat, J. A. Preston, M. L. Dunkley, P. S. Foster, P. G. Gibson, and P. M. Hansbro. 2011. Haemophilus influenzae infection drives IL-17-mediated neutrophilic allergic airways disease. PLoS Pathog. 7: e1002244.
14. Essilfie, A.-T., J. L. Simpson, M. L. Dunkley, L. C. Morgan, B. G. Oliver, P. G. Gibson, P. S. Foster, and P. M. Hansbro. 2012. Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma. Thorax 67: 588-599.
15. Horvat, J. C., M. R. Starkey, R. Y. Kim, K. W. Beagley, J. A. Preston, P. G. Gibson, P. S. Foster, and P. M. Hansbro. 2010. Chlamydial respiratory infection during allergen sensitization drives neutrophilic allergic airways disease. J. Immunol. 184: 4159-4169.
16. Beckett, E. L., R. L. Stevens, A. G. Jarnicki, R. Y. Kim, I. Hanish, N. G. Hansbro, A. Deane, S. Keely, J. C. Horvat, M. Yang, et al. 2013. A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis. J. Allergy Clin. Immunol. 131: 752-762.e757.
17. Menning, A., U. E. Höpken, K. Siegmund, M. Lipp, A. Hamann, and J. Huehn. 2007. Distinctive role of CCR7 in migration and functional activity of naive-And effector/memory-like Treg subsets. Eur. J. Immunol. 37: 1575-1583.
18. Fantini, M. C., S. Dominitzki, A. Rizzo, M. F. Neurath, and C. Becker. 2007. In vitro generation of CD4+CD25+ regulatory cells from murine naive T cells. Nat. Protoc. 2: 1789-1794.
19. Pacífico, L. G. G., F. A. V. Marinho, C. T. Fonseca, M. M. Barsante, V. Pinho, P. A. Sales-Junior, L. S. Cardoso, M. I. Araú jo, E. M. Carvalho, G. D. Cassali, et al. 2009. Schistosoma mansoni antigens modulate experimental allergic asthma in a murine model: a major role for CD4+CD25+Foxp3+ T cells independent of interleukin-10. Infect. Immun. 77: 98-107.
20. Lewkowich, I. P., S. Lajoie, J. R. Clark, N. S. Herman, A. A. Sproles, and M. Wills-Karp. 2008. Allergen uptake, activation, and IL-23 production by pulmonary myeloid DCs drives airway hyperresponsiveness in asthma-susceptible mice. PLoS One 3: e3879.
21. Zheng, S. G., J. Wang, P. Wang, J. D. Gray, and D. A. Horwitz. 2007. IL-2 is essential for TGF-b to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J. Immunol. 178: 2018-2027.
22. Couper, K. N., P. A. Lanthier, G. Perona-Wright, L. W. Kummer, W. Chen, S. T. Smiley, M. Mohrs, and L. L. Johnson. 2009. Anti-CD25 antibody-mediated depletion of effector T cell populations enhances susceptibility of mice to acute but not chronic Toxoplasma gondii infection. J. Immunol. 182: 3985-3994.
23. Wilson, M. S., M. D. Taylor, A. Balic, C. A. M. Finney, J. R. Lamb, and R. M. Maizels. 2005. Suppression of allergic airway inflammation by helminthinduced regulatory T cells. J. Exp. Med. 202: 1199-1212.
24. Takahashi, T., Y. Kuniyasu, M. Toda, N. Sakaguchi, M. Itoh, M. Iwata, J. Shimizu, and S. Sakaguchi. 1998. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10: 1969-1980.
25. Kearley, J., J. E. Barker, D. S. Robinson, and C. M. Lloyd. 2005. Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J. Exp. Med. 202: 1539-1547.
26. Ostroukhova, M., Z. Qi, T. B. Oriss, B. Dixon-McCarthy, P. Ray, and A. Ray. 2006. Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-b. J. Clin. Invest. 116: 996-1004.
27. Duan, W., T. So, A. K. Mehta, H. Choi, and M. Croft. 2011. Inducible CD4+ LAP+Foxp3- regulatory T cells suppress allergic inflammation. J. Immunol. 187: 6499-6507.
28. Soroosh, P., T. A. Doherty, W. Duan, A. K. Mehta, H. Choi, Y. F. Adams, Z. Mikulski, N. Khorram, P. Rosenthal, D. H. Broide, and M. Croft. 2013. Lungresident tissue macrophages generate Foxp3+ regulatory T cells and promote airway tolerance. J. Exp. Med. 210: 775-788.
29. Jain, N., H. Nguyen, C. Chambers, and J. Kang. 2010. Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity. Proc. Natl. Acad. Sci. USA 107: 1524-1528.
30. Wing, K., Y. Onishi, P. Prieto-Martin, T. Yamaguchi, M. Miyara, Z. Fehervari, T. Nomura, and S. Sakaguchi. 2008. CTLA-4 control over Foxp3+ regulatory T cell function. Science 322: 271-275.
31. Lehmann, J., J. Huehn, M. de la Rosa, F. Maszyna, U. Kretschmer, V. Krenn, M. Brunner, A. Scheffold, and A. Hamann. 2002. Expression of the integrin aEb7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells. Proc. Natl. Acad. Sci. USA 99: 13031-13036.
32. Suffia, I., S. K. Reckling, G. Salay, and Y. Belkaid. 2005. A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection. J. Immunol. 174: 5444-5455.
33. Collison, L. W., C. J. Workman, T. T. Kuo, K. Boyd, Y. Wang, K. M. Vignali, R. Cross, D. Sehy, R. S. Blumberg, and D. A. A. Vignali. 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450: 566-569.
34. Soroosh, P., and T. A. Doherty. 2009. Th9 and allergic disease. Immunology 127: 450-458.
35. Elyaman, W., E. M. Bradshaw, C. Uyttenhove, V. Dardalhon, A. Awasthi, J. Imitola, E. Bettelli, M. Oukka, J. van Snick, J.-C. Renauld, et al. 2009. IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc. Natl. Acad. Sci. USA 106: 12885-12890.
36. Sutmuller, R. P. M., M. H. den Brok, M. Kramer, E. J. Bennink, L. W. J. Toonen, B.-J. Kullberg, L. A. Joosten, S. Akira, M. G. Netea, and G. J. Adema. 2006. Toll-like receptor 2 controls expansion and function of regulatory T cells. J. Clin. Invest. 116: 485-494.
37. Chen, Q., T. S. Davidson, E. N. Huter, and E. M. Shevach. 2009. Engagement of TLR2 does not reverse the suppressor function of mouse regulatory T cells, but promotes their survival. J. Immunol. 183: 4458-4466.
38. Doganci, A., T. Eigenbrod, N. Krug, G. T. De Sanctis, M. Hausding, V. J. Erpenbeck, B. Haddad, H. A. Lehr, E. Schmitt, T. Bopp, et al. 2005. The IL-6Ra chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo. J. Clin. Invest. 115: 313-325.
39. Sharkhuu, T., K. I. Matthaei, E. Forbes, S. Mahalingam, S. P. Hogan, P. M. Hansbro, and P. S. Foster. 2006. Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity. Clin. Exp. Allergy 36: 1575-1583.
40. Wu, Y., M. Borde, V. Heissmeyer, M. Feuerer, A. D. Lapan, J. C. Stroud, D. L. Bates, L. Guo, A. Han, S. F. Ziegler, et al. 2006. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126: 375-387.
41. Okano, M., M. Azuma, T. Yoshino, H. Hattori, M. Nakada, A. R. Satoskar, D. A. Harn, Jr., E. Nakayama, T. Akagi, and K. Nishizaki. 2001. Differential role of CD80 and CD86 molecules in the induction and the effector phases of allergic rhinitis in mice. Am. J. Respir. Crit. Care Med. 164: 1501-1507.
42. Zheng, Y., C. N. Manzotti, M. Liu, F. Burke, K. I. Mead, and D. M. Sansom. 2004. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. J. Immunol. 172: 2778-2784.
43. Boissonnas, A., A. Scholer-Dahirel, V. Simon-Blancal, L. Pace, F. Valet, A. Kissenpfennig, T. Sparwasser, B. Malissen, L. Fetler, and S. Amigorena. 2010. Foxp3+ T cells induce perforin-dependent dendritic cell death in tumordraining lymph nodes. Immunity 32: 266-278.